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The incorporation of histone H3 variants has been
implicated in the epigenetic memory of cellular state.
Using genome editing with zinc-finger nucleases
to tag endogenous H3.3, we report genome-wide
profiles of H3 variants in mammalian embryonic
stem cells and neuronal precursor cells. Genome-
wide patterns of H3.3 are dependent on amino acid
sequence and change with cellular differentiation at
developmentally regulated loci. The H3.3 chaperone
Hira is required for H3.3 enrichment at active and
repressed genes. Strikingly, Hira is not essential for
localization of H3.3 at telomeres and many transcrip-
tion factor binding sites. Immunoaffinity purification
and mass spectrometry reveal that the proteins
Atrx and Daxx associate with H3.3 in a Hira-indepen-
dent manner. Atrx is required for Hira-independent
localization of H3.3 at telomeres and for the repres-
sion of telomeric RNA. Our data demonstrate that
multiple and distinct factors are responsible for
H3.3 localization at specific genomic locations in
mammalian cells.678 Cell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc.INTRODUCTION
Genetic and biochemical evidence have recently converged
to connect epigenetic mechanisms at the level of chromatin
(Bernstein et al., 2007; Goldberg et al., 2007; Henikoff, 2008).
In addition to nucleosome remodeling and covalent modifi-
cations, eukaryotic cells generate variation in chromatin by
the introduction of variant histone proteins (Henikoff, 2008).
Mammalian cells express three major types of noncentromeric
histone H3 variants, H3.1, H3.2, and H3.3 (Hake and Allis,
2006; Hake et al., 2006). Although histone H3.3 differs from
H3.2 and H3.1 at only four or five amino acids (Figure S1A avail-
able online), H3.3 is specifically enriched at transcriptionally
active genes and regulatory elements in nonpluripotent cells
(Ahmad and Henikoff, 2002; Jin et al., 2009; Mito et al., 2005,
2007).
Histone H3.3 is incorporated into chromatin in both a replica-
tion-coupled (RC) and replication-independent (RI) manner,
while the incorporation of H3.2 is coupled to replication (Ahmad
and Henikoff, 2002; De Koning et al., 2007). The histone chap-
erone CAF-1 is found in a complex with H3.1 and mediates RC
nucleosome assembly (Smith and Stillman, 1989; Tagami
et al., 2004). In contrast, the histone chaperone Hira has been
found in a complex with H3.3 and mediates RI nucleosome
assembly (Ray-Gallet et al., 2002; Tagami et al., 2004).
Hira has been implicated in H3.3-specific deposition and chro-
matin assembly (Loyola and Almouzni, 2007). Although Hira is
required for chromatin assembly and H3.3 deposition in the
male pronucleus of Drosophila, Hira is not required for global
H3.3 deposition in Drosophila embryos or adult cells, suggesting
that alternate pathways may mediate H3.3 nucleosome assem-
bly (Bonnefoy et al., 2007; Loppin et al., 2005). Indeed, the chro-
matin remodeling factor CHD1 was shown to physically asso-
ciate with Hira and has been suggested to work with Hira to
mediate H3.3 incorporation into chromatin in Drosophila (Konev
et al., 2007).
In Drosophila, both Hira and H3.3 are required for fertility and
for transcriptional regulation of specific genes, but not for devel-
opmental viability (Bonnefoy et al., 2007; Ho¨dl and Basler, 2009;
Nakayama et al., 2007; Sakai et al., 2009). However, in mice, tar-
geted mutagenesis of Hira results in a more severe phenotype,
with gastrulation defects leading to early embryonic lethality
(Roberts et al., 2002). Given the conserved association between
H3.3 and active chromatin, H3.3 has been speculated to play an
important role in mammalian embryonic stem cells (ESCs)
(Creyghton et al., 2008; Gaspar-Maia et al., 2009). However,
no genome-wide studies in pluripotent cells distinguish between
H3 variants, nor do they examine the genome-wide role of Hira or
other histone chaperones in specifying H3.3 localization at
specific genomic regions.
Here, we report genome-wide profiles of histone H3 variant
localization in mammalian ESCs and neuronal precursor cells
(NPCs), and we establish the dependence and independence
of these patterns on Hira. We find that Hira is required for
genome-wide H3.3 enrichment at active and repressed genes
in ESCs. Surprisingly, H3.3 enrichment at many transcription
factor binding sites (TFBS) and telomeres is Hira independent.
To identify factors that might mediate specific Hira-independent
localization of H3.3, we use immunoprecipitation and mass
spectrometry. We identify Atrx and Daxx as proteins that specif-
ically associate with H3.3 in both pluripotent and nonpluripotent
cells, both in the presence and in the absence of Hira. Unlike
Hira, Atrx is not required for H3.3 localization at genes or
TFBS. However, Atrx is specifically required for enrichment of
H3.3 at telomeres in ESCs, and for the repression of telomeric
RNA.
RESULTS
Genome-wide Patterns of H3.3 Enrichment
Are Dependent upon Endogenous Amino Acid Sequence
To distinguish H3 variants in our study without altering endoge-
nous levels of H3 variant expression, we used designed zinc-
finger nucleases (ZFNs) (Carroll, 2008) in both gene addition
(Moehle et al., 2007) and correction (Urnov et al., 2005) modes
to engineer a panel of heterozygous ESC lines carrying one allele
of wild-type H3.3B and another allele of H3.3B with a C-terminal
EYFP tag (H3.3-EYFP), HA tag (H3.3-HA), or H3.3B with an
epitope tag and simultaneous mutation toward H3.2 or H3.1
(H3.2-EYFP,H3.1-EYFP,H3.2-HA, andH3.1S31-HA) (Figure S1).
All heterozygously tagged ESCs retain three ‘‘wild-type’’ copies
of H3.3 genes, including one copy of unmodified H3.3B (Fig-
ure S1G), and two copies of H3.3A. Western blots demonstrateequal protein expression in the epitope-tagged H3 variant ESC
lines (Figure S1H).
To assess the genome-wide localization of histone H3 variants
at high resolution, we used chromatin immunoprecipitation fol-
lowed by massively parallel sequencing (ChIP-seq) (Barski
et al., 2007; Mikkelsen et al., 2007). We found 10,099 total genic
and intergenic regions highly enriched for H3.3 in crosslinking
ChIP-seq of ESCs, in contrast to 1442 regions enriched for
H3.2, and we observe that gene-rich regions of the genome
show greater enrichment of H3.3 than H3.2 (Figures 1A and
1B). On a chromosomal scale map, H3.3 enrichment correlates
with markers of transcription, including Ser-5 phosphorylated
RNA polymerase II (RNAPII), H3K4me3, H3K36me3, and
H3K4me1 (Figure 1A). Unbiased clustering analyses confirm
the genome-wide correlation of H3.3 with active histone modi-
fications, particularly H3K4me1 (Table S1). Despite different
epitope tags, we found extremely similar profiles of H3.3-HA
and H3.3-EYFP (Figure 1A, Table S1, Figures S2A and S2B).
Genome-wide analysis also reveals specific enrichment of
H3.3 at previously identified genic and intergenic ESC TFBS
(Chen et al., 2008), as well as peaks of H3.3 in specific unanno-
tated intergenic regions (Figure 1B).
To analyze H3 variant enrichment in different classes of
repeats, we determined the relative enrichment of specific
repeat sequences from our ChIP-seq experiments and com-
pared it to that from control input DNA. H3.3 was reproducibly
depleted in satellite repeat sequences and in Y-chromosomal
repeat DNA (Figure 1C). We found the most significant enrich-
ment of H3.3 in the (TTAGGG)n repeat that is the conserved
telomeric DNA sequence among vertebrates (Meyne et al.,
1989) (Figure 1C). This telomeric enrichment of H3.3 is consistent
with telomeric foci of incorporation visible on the largely hetero-
chromatic Y chromosome (Figures S1J–S1O), and with a recent
report of telomeric localization of transfected epitope-tagged
H3.3 in ESCs (Wong et al., 2009). Mutation of H3.3B to H3.2 or
H3.1S31 alters genome-wide patterns of H3.3 enrichment,
demonstrating that the amino acid sequence of an endogenous
H3.3 gene determines its genomic localization in mammalian
cells.
H3.3 Is Enriched at TSS of Active and Repressed HCP
Genes, and in the Bodies and TES of Transcribed
Sequences
As there has been some disagreement regarding the patterns of
H3.3 at active versus repressed genes in vertebrates (Jin and
Felsenfeld, 2006; Jin et al., 2009; Sutcliffe et al., 2009; Tamura
et al., 2009), we used ChIP-seq to address the genome-wide
patterns of H3 variant enrichment around gene transcription start
sites (TSS) in mouse ESCs. We find that H3.3 is not exclusively
a marker of transcriptionally active genes in ESCs and NPCs.
Previous studies show that the majority of genes with high
CpG content promoters (HCP genes) in both ESCs and differen-
tiated cells are marked by histone H3K4me3 and the presence of
RNAPII, regardless of whether the gene is active or repressed
(Barski et al., 2007; Guenther et al., 2007; Mikkelsen et al.,
2007). When we divide HCP genes into low, medium, and high
expression in ESCs (see the Experimental Procedures), we find
that H3.3, like H3K4me3 and RNAPII, is enriched around theCell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc. 679
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Figure 1. Genomic Localization of Histone H3.3 Is Dependent on
Amino Acid Sequence
(A) ChIP-seq profiles across 120 MB of chromosome 1 in mouse ESCs, with
antibodies as indicated. The y axis represents the number of reads spanning
a genomic position [scale on right (baseline, maximum)]. CpG islands (green)
and genes [refseq (+) and refseq ()] are shown below plots. Data for general
H3 in ESCs are from Mikkelsen et al. (2007).
(B) Annotations of H3 variant enriched regions. The y axis is the number of en-
riched regions identified for each H3 variant, while the x axis represents
different categories of gene annotation and ESC TFBS (defined in Chen
et al., 2008).
(C) Association of H3.3 with repetitive elements. Data are presented as fold
enrichment over input. SAT, satellite repeats; (TTAGGG)n, telomeric DNA
repeats.
See Figure S1 for details of ZFN-mediated generation and characterization of
ESC lines and Table S1 for genome-wide correlation of ChIP-seq data sets.TSS of both active and repressed genes (Figure 2A). In both
native and crosslinking ChIP-seq, we find H3.3 less enriched at
the TSS itself (Figures 2A and 2D, Figures S2A–S2D). This deple-
tion of the 1 nucleosome at the TSS of active and inactive
genes (Schones et al., 2008) has been attributed both to the680 Cell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc.instability of nucleosomes containing H3.3 and H2A.Z and to
the presence of specific sequences at CpG promoters that
directly reduce nucleosome stability (Jin et al., 2009; Ramirez-
Carrozzi et al., 2009).
More than one-fifth of HCP genes in ESCs carry both
H3K4me3 and H3K27me3 in their promoters, and these tran-
scriptionally repressed ‘‘bivalent’’ genes are proposed to repre-
sent genes that are poised for activation after cell differentiation
(Bernstein et al., 2006; Mikkelsen et al., 2007). When we analyze
the pattern of H3 variants at bivalent TSS by ChIP-seq, we find
that H3.3 is enriched around the TSS of bivalent genes in
ESCs, while mutation of H3.3 toward H3.2 or H3.1 abolishes
this enrichment (Figure 2G, Figure S3).
Although H3.3 is incorporated around the TSS of both active
and repressed genes in ESCs, H3.3 is enriched in the body of
active genes, but not that of repressed genes (Figures 2A, 2G,
and 2H, Figures S2A–S2D). Mononucleosome resolution anal-
ysis indicates that H3.3 is incorporated into the +1 nucleosomes
in both active and repressed genes, but up to +3 nucleosomes
and further into the coding regions of active genes (Figures
S2Q–S2W). The level of H3.3 in gene bodies is correlated with
gene expression, particularly at highly expressed genes (Spear-
man’s rank correlation coefficient r = 0.54, p < 2.2e-16; see
Figure 2A and Figure S2). Upon mutation of H3.3 to H3.2 or
H3.1S31, H3.3 specific patterns of enrichment around the TSS
and gene body are lost, generating patterns similar to general
H3 (Figures 2B and 2D).
In accordance with previous studies (Henikoff et al., 2009; Jin
et al., 2009; Mito et al., 2005), H3.3 enrichment often extends
beyond the gene body and past the transcriptional end site
(TES) at highly expressed genes in ESCs (Figures 2A and 2H)
and in differentiated NPCs (Figure S2CC). At highly expressed
genes such as beta-actin (Actb), H3.3 enrichment increases
immediately after the TES, and peaks at approximately
+700 bp ± 200 bp after the TES (Figure 2H, Figures S2A–S2D).
We observe a similar pattern of H3.3 localization in the bodies
and after the TES of transcribed noncoding RNA (Guttman
et al., 2009) (Figure 2I). Interestingly, the distribution of post-
TES peaks of serine-5-phosphorylated RNAPII are closely colo-
calized with peaks of H3.3 at active genes, with the phosphory-
lated RNAPII peak slightly downstream (200 bp) from the H3.3
peak.We did not observe any significant post-TES enrichment of
histone modifications that are associated with active genes,
such as H3K4me3, H3K4me1, and H3K36me3 (Figures 2E and
2F, Figure S2). Post-TES enrichment of H3.3 is also dependent
on amino acid sequence (Figures 2B and 2D, Figure S2). From
these analyses, we conclude that H3.3 is localized around the
TSS of both active and repressed HCP genes and that both
H3.3 and phosphorylated RNAPII are significantly enriched
beyond the TES of highly expressed genes in undifferentiated
and differentiated mammalian cells.
The Profile of H3.3 at Cell Type-Specific Genes
and Regulatory Elements Changes with Cell
Differentiation
To determine how genome-wide patterns of H3.3 change with
cell differentiation, we differentiated both H3.3-HA and H3.2-HA
ESCs to NPCs (Figure S3A) (Conti et al., 2005). In ESCs, H3.3 is
enriched in the bodies of expressed pluripotency genes such as
Esrrb, Nanog, and Oct4, correlated with H3K36me3 (Figure 3A,
Table S2, Figure S3B). Upon differentiation of ESCs to NPCs,
the expression of most pluripotency genes is lost (Conti et al.,
2005). Accordingly, the enrichment of H3.3 and H3K36me3 in
the bodies of pluripotency genes largely disappears upon cell
differentiation (Figure 3A, Figure S3B).
After differentiation of ESCs to NPCs, the profile of H3.3
changes with resolution of bivalent domains. In bivalent ES
genes that resolve to H3K4me3 and become transcriptionally
active in NPCs, H3.3 is maintained around the TSS and also
incorporated into the gene body, in correlation with H3K36me3
and H3K4me1 (Figure 3B, Figure S3C). For example, upon differ-
entiation to NPCs, H3.3 extends into the gene body of the active
epidermal growth factor receptor gene Egfr, correlating with
H3K36me3 and H3K4me1 (Figure 3B). In contrast, for bivalent
genes that remain transcriptionally repressed and resolve to
either H3K27me3 or no mark in NPCs, H3.3 enrichment is
reduced at the TSS upon differentiation (Figure S3C). As ex-
pected, H3.2 remains unenriched at the TSS in both ESCs and
NPCs (Figure S3C).
While the pattern of H3.3 changes at cell type-specific
genes, housekeeping genes that remain highly expressed
through differentiation retain similar enriched patterns of H3.3
incorporation. For example, H3.3 remains enriched around the
TSS and within the gene body of the housekeeping gene lactate
dehydrogenase A Ldha (Figure 3C, Figure S3A). In both ESCs
and NPCs, we find the greatest enrichment of H3.3 at highly
expressed metabolic and housekeeping genes (Figure S3D).
Our data show that the overall relationship between H3.3 incor-
poration and gene expression is retained in ESCs and NPCs,
with H3.3 and H3K4 methylation marking the TSS of active and
poised HCP genes, and H3.3 enriched in the body and TES of
active HCP genes. At cell type-specific genes, H3.3 localization
changes with cellular state.
Genome-scale studies have demonstrated that in addition to
genes (Mito et al., 2005), H3.3 replacement marks the bound-
aries of regulatory elements (Jin et al., 2009; Mito et al., 2007).
Thirty-six percent (3627) of H3.3 enriched regions in mouse
ESCs are located outside of known annotated genes (Figures
1B and 3D–3F). We therefore compared our genome-wide distri-
butions for histone H3 variants in ESCs and NPCs with estab-
lished genome-wide maps for 13 distinct sequence-specific
TFs in ESCs (Chen et al., 2008). We find that H3.3 is enriched
genome-wide at genic and intergenic TFBS for all 13 character-
ized TFs in ESCs (Figure 3D, Figure S3E). Remarkably, 3878
(38%) of the overall regions enriched for H3.3 in ESCs (Figure 1B)
correspond to previously identified TFBS (Chen et al., 2008).
Again, peaks of H3.3 at TFBS are dependent on H3.3 amino
acid sequence (Figures 3D–3G, Figure S3E).
Many of the specific peaks of H3.3 at TFBS are cell-type
specific, especially those located in intergenic regions (Figures
1B and 3D–3G, Figure S3B, data not shown). We find that H3.3
incorporation at TFBS bound by multiple TFs increases signifi-
cantly with the number of bound TFs in ESCs, but these same
elements do not show increased H3.3 in NPCs (Figure 3F,
Figure S3F). Genomic locations bound by more than four TFs
are called multiple transcription factor-binding loci (MTL), anda subset of MTL bound by Oct4-Sox2-Nanog have been shown
to serve as ESC-specific enhanceosomes (Chen et al., 2008). For
example, an intergenic region near the AP-2 transcription factor
gene Tcfap2c is a target for multiple transcription factors in ESCs
(Chen et al., 2008). We find H3.3 enriched at this region specifi-
cally in ESCs, with enrichment lost in NPCs (Figure 3F).
After differentiation to NPCs, genome-wide enrichment of
H3.3 at ESC TFBS is reduced, but not eliminated (Figure 3E,
Figure S3E). At some specific TFBS (Figure 3F), H3.3 and
H3K4me1 enrichment is lost upon differentiation to NPCs.
However, at other TFBS, such as those 50 and 30 of Nanog,
H3.3 and H3K4me1 enrichment is reduced but partially main-
tained (Figure S3B). H3K4me1 and H3.3 have been separately
shown to significantly colocalize with TFBS and other regulatory
elements (Heintzman et al., 2007; Mito et al., 2007; Wang et al.,
2008), but the patterns of H3.3 and H3K4me1 have never been
directly compared. In our analysis, 26% of H3K4me1 peaks
overlap with H3.3 peaks, and peaks of H3.3 are five times
more likely to be associated with peaks of H3K4me1 than
H3K4me3 (Table S1, p < 0.00001). In addition to ESC-specific in-
tergenic peaks of H3.3 and H3K4me1 (Figure 3F), we also found
724 intergenic peaks of H3.3 and H3K4me1 that are specific to
differentiated NPCs and that do not correspond to any known
TFBS (Figure 3G, data not shown). It is possible that these repre-
sent uncharacterized cell type-specific enhancers. Overall, our
data demonstrate that the genome-wide localization of H3.3
changes with cell differentiation at cell type-specific genes and
regulatory elements.
Hira Is Required for Enrichment of H3.3 at Active
and Repressed Genes
After establishing genome-wide patterns of H3.3 in undifferenti-
ated ESCs and differentiated NPCs, we sought to determine
whether these patterns were dependent on the H3.3 chaperone
Hira. We therefore used ZFNs to tag one allele of the endoge-
nous H3.3B gene in Hira/ ESCs (Meshorer et al., 2006; Roberts
et al., 2002) with a C-terminal EYFP tag (Figure 4A, Figure S4A),
and compared the genome-wide localization of H3.3-EYFP in
the presence and absence of Hira.
Using native ChIP-seq, we find that Hira is required for
genome-wide H3.3 enrichment at active and repressed HCP
genes (Figures 4B–4G). In the absence of Hira, the pattern of
H3.3 around active and repressed genes resembles H3.2, with
no enrichment surrounding the TSS, and depletion of H3.3 at
the TSS itself (Figures 4D and 4E). For example, in Hira/
ESCs, the enrichment of H3.3 around the TSS of the repressed
bivalent gene Pparg is abolished (Figure 4F). At highly expressed
housekeeping genes such as the ribosomal protein-coding gene
Rps19, the gene body and post-TES enrichment of H3.3 is simi-
larly decreased in the absence of Hira (Figure 4G). Our data
demonstrate that the vast majority of H3.3 enrichment at both
active and repressed genes in ESCs is Hira dependent.
One possible explanation for the loss of H3.3 localization at
active and repressed genes in Hira/ ESCs is a significant alter-
ation in patterns of gene expression. Remarkably, microarray
analysis reveals that global patterns of ESC gene expression
are maintained in Hira/ ESCs (Figures S4B–S4D). Moreover,
genome-wide patterns of H3K36me3 are extremely similar inCell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc. 681
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Figure 2. Specific Patterns of H3.3 and Phosphorylated RNA Polymerase at Active and Repressed Genes
(A–F) Profiles of H3 variants, H3, H3 modifications, or RNAPII as indicated above each panel across the TSS and TES for highly active (red), medium expressing
(black), or low expressing (green) CpG-rich genes in ESCs. The y axis represents the average number of tags per gene per 200 bp per 1,000,000 mapped reads.
H3 data are from Mikkelsen et al. (2007). (A)–(E) are from crosslinking ChIP-seq, while (F) is from native ChIP-seq.
(G) H3.3 is enriched around the TSS, but not into the gene body of the H3K4me3/H3K27me3 bivalent and transcriptionally repressed Zfpm2 gene in ESCs.
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Figure 3. Cell Type-Specific Enrichment of
H3.3 at Transcription Factor Binding Sites
and Developmentally Regulated Genes
(A) H3.3, H3K4me1, and H3K36me3 are enriched
in the gene body of the highly expressed pluripo-
tency gene Esrrb in ESCs, and this enrichment is
largely lost upon differentiation to NPCs.
(B) The epidermal growth factor receptor gene Egfr
is H3K4me3/H3K27me3 bivalent and transcrip-
tionally repressed in ESCs. Upon differentiation
to NPCs, H3.3, H3K4me1, and H3K36me3 are en-
riched in the Egfr gene body.
(C) H3.3, H3K4me1, and H3K36me3 are enriched
in the gene body of the housekeeping gene lactate
dehydrogenase A Ldha in both ESCs and NPCs
and is not enriched in the neighboring Ldhc gene.
(D and E) H3.3 is enriched genome-wide around
ESC TFBS. Crosslinking ChIP-seq genome-wide
profiles of H3 variants as indicated around ESC
binding sites for Nanog, Oct4, Sox2, Smad1, and
STAT3. TFBS inmouse ESCswere from a previous
ChIP-seq study (Chen et al., 2008), and classified
as promoter (black), gene body (dark blue), or in-
tergenic (light blue). (D) represents data from
ESCs, while (E) represents data from NPCs at
identical regions. The y axis represents number
of tags per binding site per 200 bp per 1,000,000
mapped reads. Data for H3 in ESCs are from (Mik-
kelsen et al., 2007).
(F) H3.3 and H3K4me1 are enriched at an inter-
genic region bound by multiple transcription
factors (Chen et al., 2008) specifically in ESCs.
(G) H3.3 and H3K4me1 are enriched at an inter-
genic region specifically in NPCs.
The y axes in (A)–(C) are identical (indicated in the
right side of C). In (A)–(E), ‘‘(native)’’ indicates
native H3.3-HA ChIP-seq, and ‘‘(replicate)’’ indi-
cates biological replicate H3.3-HA ChIP-seq from
F1 hybrid ESC background. See also Figure S3.wild-type and Hira/ ESCs (Figures S4E–S4H). This result is
similar to the recent observation that global patterns of ESC
gene expression are maintained following knockdown of CHD1
(Gaspar-Maia et al., 2009). We conclude that genome-wide
enrichment of H3.3 at active and repressed genes is Hira depen-
dent but is not required for maintenance of the undifferentiated
ESC transcriptome.
Hira-Independent Enrichment of H3.3 at Transcription
Factor Binding Sites
We next examined the Hira dependence of H3.3 enrichment at
genic and intergenic TFBS. Surprisingly, global H3.3 profiles(H) H3.3 and RNAPII Ser5p are enriched in the gene body and after the TES of the
8WG16 track are from Mikkelsen et al. (2007). RNA-seq data are from Cloonan e
(I) H3.3 is enriched around the TSS and into the body of the noncoding RNA gen
Zbtb37 gene in ESCs. Data are represented as in Figure 1A. Gene is shown to sca
rectangles above the gene represent CpG islands.
In (G)–(I), hybrid indicates F1 hybrid ES background. See also Figure S2.are largely maintained at ESC TFBS in Hira/ ESCs (Figure 5A,
Figure S5, Table S3), indicating that H3.3 enrichment at most
known regulatory elements is Hira independent. For example,
H3.3 enrichment at an intergenic MTL approximately 30 kb
from theMmp17 gene is maintained in Hira/ ESCs (Figure 5B),
as is H3.3 enrichment at an intergenic MTL near the repressed
Foxi3 gene (Figure 5C). Indeed, levels of H3.3 are increased at
some TFBS in Hira/ ESCs (Figure S5A). However, levels of
H3.3 are also reduced at other TFBS in Hira/ ESCs (Table S3,
Figure S5B). Of all previously identified ESC TFBS (Chen et al.,
2008), 34% show greater than 2-fold more H3.3 tags in Hira+/+
than in Hira/, while 12% show greater than 2-fold more H3.3highly expressed gene Actb (beta-actin) in ESCs. Data for the RNAPII unphos
t al. (2008).
e Gas5, but less enriched in the gene body of the neighboring low expressing
le below plot, with start and direction or transcription indicated by arrow. Green
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Figure 4. Enrichment of H3.3 at Active and Repressed Genes Is Hira Dependent
(A) Immunoblots showing expression of H3.3-EYFP in wild-type and Hira/ ESCs, with antibodies as indicated.
(B–E) Native ChIP-seq profiles of H3 variants, in wild-type ESCs (B–D) and Hira/ ESCs (E) across the TSS and TES for highly active (red), medium expressing
(black), or low expressing (green) CpG-rich genes, with data represented as in Figure 2. See also Figure S4.
(F) H3.3 enrichment at the TSS of repressed bivalent gene Pparg is Hira dependent.
(G) H3.3 enrichment at the active, ribosomal-protein coding gene Rps19 is Hira dependent.tags in Hira/, indicating that targeting of H3.3 to the majority
(54%) of known ESC TFBS is Hira independent (Table S3,
Figure S5). Global profiles of H3K4me1 are very similar in wild-
type and Hira/ ESCs (Figures S4E, S4F, and S5D), indicating
that Hira is also not required to maintain the localization of
H3K4me1. Overall, these data demonstrate that Hira is not
essential for the localization of H3.3 at many TFBS inmammalian
ESCs.
Hira-Independent Association of Atrx and Daxx
with Histone H3.3
To identify candidates that might mediate Hira-independent
localization of H3.3, we used immunoaffinity purification and
mass spectrometry (Cristea et al., 2005) (Figure 6A, Figure S6).
We found many interacting proteins common to all H3 variants684 Cell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc.in wild-type andHira/ ESCs, including core histones and previ-
ously described members common to both RC and RI chromatin
assembly complexes, such as Nasp, Asf1a, Asf1b, and Rbap48
(see Table S4). Notably, the previously described H3.3 chap-
erone Hira (Tagami et al., 2004) was identified specifically in
proteins isolated with H3.3 (Figures 6A and 6B).
In addition to Hira, we also identified Atrx and Daxx as proteins
that specifically associate with H3.3 (Figures 6A and 6B). Atrx is
a member of the SNF2 family of chromatin remodeling factors
(Picketts et al., 1996). Mutations of human ATRX give rise to the
ATR-X syndrome, a disorder characterized by a form of X-linked
mental retardation that is frequently associated with alpha thal-
assemia (Gibbons et al., 2008). ATRX coexists in a chromatin-
remodeling complex with the death domain-associated pro-
tein Daxx, and these proteins localize to heterochromatin and
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Figure 5. Hira Is Not Essential for H3.3 Enrichment at Transcription Factor Binding Sites
(A) Native ChIP-seq genome-wide profiles of H3.3 around previously described ESC TFBS (Chen et al., 2008), with data analyzed as in Figure 3.
(B and C) Localization of H3.3 in ESCs at intergenic enhancer elements near Mmp17 (B) and Foxi3 (C) is Hira independent.
See also Figure S5 and Table S3.promyelocytic leukemia (PML) nuclear bodies in human and
mouse cells (Tang et al., 2004; Xue et al., 2003). As Atrx and
Daxx specifically associate with H3.3 in both wild-type
and Hira/ ESCs, we conclude that this association is Hira
independent.
To determine whether the association betweenH3.3, Atrx, and
Daxx was conserved in differentiated human cells, we isolated
oligonucleosomes and chromatin-associated proteins from
HeLa cells stably expressing FLAG-HA tagged H3.3 or H3.1
(Tagami et al., 2004) (Figures 6C and 6D). After FLAG affinity
purification, immunoblots of H3.3- and H3.1-associated proteins
reveal that both Daxx and Atrx are specifically associated
with H3.3 but not H3.1 oligonucleosomes in human cells
(Figure 6E).
Atrx Is Required to Maintain H3.3 Localization
at Telomeres and for Repression of Telomeric
Repeat-Containing RNA in ESCs
To determine whether Atrx is required for H3.3 localization, we
again used ZFNs to knock in an epitope tag into the endogenous
allele of H3.3B, generating heterozygous H3.3B/H3.3B-EYFP in
Atrxflox and Atrxnull mouse ESCs (Garrick et al., 2006) (Figure 7A).
We then used native ChIP-seq to generate genome-wide profiles
of H3.3 in the presence and absence of Atrx. We find that Atrx
is not required for H3.3 incorporation at active or repressed
genes, or at regulatory elements (Figures S5A and S7A–S7E),
as genome-wide profiles of H3.3 are similar at genes and
TFBS in Atrxflox and Atrxnull ESCs. Strikingly, both ChIP-seq
(Figure 7B) and cell imaging analysis (Figure 7C) demonstrate
that Atrx, but not Hira, is specifically required for H3.3 enrich-
ment at telomeres. In accordance with the requirement of Atrx
for telomeric localization of H3.3, ChIP analysis shows thatAtrx itself is physically associated with telomeres in Atrxflox
ESCs (Figure 7D).
To investigate the functional consequences of Atrx deletion
and the loss of Atrx-dependent telomeric enrichment of H3.3,
we examined the chromatin state and transcriptional output
of ESC telomeres. The chromatin of ESC and induced pluripo-
tent cell telomeres has previously been shown to have lower
levels of the heterochromatin marker H3K9me3 and increased
transcription of telomeric repeat-containing RNA (TERRA) in
comparison to differentiated cells (Marion et al., 2009). In partic-
ular, TERRA has recently been identified as a component of
telomeric heterochromatin, and levels of TERRA have been
shown to be regulated by chromatin modifying enzymes (Azzalin
et al., 2007; Luke and Lingner, 2009; Schoeftner and Blasco,
2008). ChIP of H3K4me3 and H3K9me3 does not show a signifi-
cant difference in telomeric enrichment between Atrxflox and
Atrxnull ESCs (Figure S7F). However, northern blots from Atrxflox,
Atrxnull, and Atrxflox ESCs 4 days after treatment with Cre reveal
reproducible (1.7-fold) upregulation of TERRA in the absence
of Atrx (Figures 7E–7G). Our data demonstrate that Atrx is
required for Hira-independent localization of H3.3 at telomeres
and for repression of TERRA.
DISCUSSION
In this study, we examine H3 variant localization in mammalian
ESCs and differentiated NPCs. Genome-wide patterns of H3.3
are dependent on H3.3-specific amino acid sequence; the
enrichment of H3.3 at cell type-specific genes and TFBS is
dependent on cellular state. We describe three general cate-
gories of H3.3 enrichment in mammalian cells: (1) genes and
other transcribed nonrepetitive sequences, (2) TFBS, andCell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc. 685
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Figure 6. Atrx and Daxx Association with
H3.3 Is Specific, Hira Independent, and
Conserved in Mouse and Human Cells
(A) H3.3-EYFP, H3.2-EYFP, H3.1-EYFP, and
Hira/ H3.3-EYFP associated proteins were im-
munopurified from heterozygous H3.3B ESCs via
the EYFP tag, resolved by SDS-PAGE, and visual-
ized by Coomassie blue. Proteins were identified
by mass spectrometry, and those listed in red
are specific to H3.3. The arrow indicating Hira
points to a polypeptide in the H3.3 lane running
immediately above the polypeptide Nasp (*), which
is common to all purified H3 variants. A full list of
identified proteins is presented in Table S4.
(B) Immunoblots of immunopurified H3 variant
associated proteins from ESCs with antibodies
as indicated. See also Figure S6.
(C) Immunoblots of Atrx, Daxx, and FLAG-HA-H3
from HeLa cells stably expressing H3.3-FLAG-
HA (FHA) or H3.1-FHA (Tagami et al., 2004).
(D) Oligonucleosomes purified from H3.3-FHA and
H3.1-FHA HeLa cells. Micrococcal nuclease
digested chromatin was incubated with M2 aga-
rose beads in order to purify H3.3-FHA and H3.1-
FHA oligonucleosomes and associated proteins.
(D and E) Two adjacent FLAG elution fractions (FE1
and FE2) from each H3.3-FHA and H3.1-FHA puri-
fication are shown. Oligonucleosomal DNA was
purified and run on a 1% agarose gel, with frag-
ment size indicated.
(E) Immunoblots of eluate from two adjacent FLAG
elution fractions (FE1 and FE2) after FLAG affinity
purification fromH3.3-FHA andH3.1-FHA oligonu-
cleosomes (D).(3) telomeres. Remarkably, we find that each of these general
categories of H3.3 enrichment in ESCs is mediated by distinct
mechanisms. As expected, Hira is required for genic enrichment
of H3.3. Unexpectedly, localization of H3.3 at specific TFBS and
telomeres is Hira independent, and we have identified Atrx as
required for H3.3 localization at telomeres. Our results demon-
strate that distinct factors control H3.3 localization at specific
genomic locations in mammalian cells.
We find that H3.3 is constitutively enriched around the TSS of
active and repressedHCPgenes inmammalian ESCs andNPCs,
including the TSS of repressed bivalent genes in ESCs. Although
a recent genome-wide study found that H3.3 is unenriched at the
TSS of repressed genes in HeLa cells (Jin et al., 2009), these
results are not necessarily in conflict with our findings. Low
CpG content promoter (LCP) and HCP genes have been
described to display distinct modes of regulation (Mikkelsen
et al., 2007; Ramirez-Carrozzi et al., 2009; Saxonov et al.,
2006). Most HCP genes show evidence of transcriptional initia-
tion, assemble unstable nucleosomes, and do not require SWI/
SNF nucleosome remodeling complexes for gene induction,
while LCP genes assemble stable nucleosomes and require
SWI/SNF (Guenther et al., 2007; Ramirez-Carrozzi et al., 2009).
Less differentiated cells such as ESCs contain large numbers
of HCP genes with characteristics of transcriptional initiation686 Cell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc.(Guenther et al., 2007; Mikkelsen et al., 2007). Indeed, nearly
all (99%) of HCP genes are marked by H3K4me3 in mouse
ESCs, whether they are transcriptionally active or repressed
(Mikkelsen et al., 2007). In contrast to HCP genes, we do not
observe any significant pattern of H3.3 enrichment at LCP genes
in ESCs and NPCs (data not shown). Our results are therefore
consistent with a model in which H3K4 methylation and H3.3
localization at HCP TSS are coupled to transcriptional initiation.
We find that enrichment of H3.3 in the gene body and after the
TES is proportional to transcriptional activity. As with previous
studies in Drosophila and human cells (Henikoff et al., 2009;
Jin et al., 2009; Mito et al., 2005), we find peaks of H3.3 after
the TES of highly active genes, and we observe that these peaks
are closely paralleled by peaks of Ser-5 phosphorylated RNAPII
itself. We demonstrate that chromatin-based ‘‘transcriptional
punctuation’’ (Siegel et al., 2009; Talbert and Henikoff, 2009)
by H3.3 and phosphorylated RNAPII marks the boundaries of
highly expressed genes in both undifferentiated and differenti-
ated mammalian cells, calling attention to a potentially more
universal mechanism for histone variant utilization as a genomic
‘‘boundary marker.’’
Our study provides a genome-wide analysis of a histone
variant in the presence and absence of a mammalian histone
chaperone. We find that H3.3 enrichment at active and
repressed genes is dependent on the histone chaperone Hira.
Previous studies suggest that H3.3 deposition in actively tran-
scribed gene bodies may be coupled to transcription, potentially
mediated by factors associated with elongating polymerase
(Daury et al., 2006; Janicki et al., 2004; Schwartz and Ahmad,
2005). Our data are consistent with Hira-dependent transcrip-
tion-coupled deposition of H3.3 at transcribed nonrepetitive
sequences.
Intriguingly, we do not observe significant abnormalities in
Hira/ ESCs, despite a global lack of H3.3 enrichment at active
and repressed genes and despite the requirement of Hira for
early embryonic development (Roberts et al., 2002). We specu-
late that Hira/ ESCs may be rescued by the replication-
coupled deposition of histones during the frequent S phases of
rapidly dividing ESCs (Burdon et al., 2002). Hira/ ESCs divide
as rapidly as wild-type ESCs and show a similar preponderance
of cells in S phase (A.C. and P.J.S., unpublished data). Overall,
our data are consistent with a role for Hira in genic deposition
of H3.3.
H3.3 enrichment has recently been shown at TFBS in
Drosophila and human cells (Jin et al., 2009; Mito et al., 2007).
Deposition of H3.3 at TFBS may serve as a mechanism for the
maintenance of regulatory elements in a more accessible chro-
matin conformation (Henikoff, 2008). Close comparison of our
data to a recent data set of 13 different TFs in mouse ESCs
(Chen et al., 2008) shows H3.3 enriched in ESCs at all known
types of TFBS genome-wide, whether in gene bodies, pro-
moters, or intergenic regions. We also find a strong positive
correlation betweenMTL and H3.3 localization, indicating partic-
ular enrichment of H3.3 at enhancer elements. Our data demon-
strate that Hira is involved in H3.3 localization at some genic and
intergenic TFBS. However, we also find that genome-wide H3.3
enrichment at many regulatory elements is Hira independent and
Atrx independent. Our data therefore suggest that H3.3 localiza-
tion at TFBS may be mediated by multiple and distinct factors,
including Hira, with as yet unidentified factors mediating H3.3
localization at specific regulatory elements.
We find that H3.3 is specifically enriched in the canonical
(TTAGGG)n repeat that is the hallmark of telomeres in verte-
brates (Meyne et al., 1989). Previous immunofluorescence
studies localizing GFP-tagged Hira to telomeres suggested
that Hira facilitates H3.3 deposition at this location (Wong
et al., 2009). However, using genome-wide ChIP-seq and cell
imaging analyses in Hira/ ESCs, we show that localization of
H3.3 at telomeres in ESCs is Hira independent. Further, we iden-
tify Atrx and Daxx as proteins that associate with H3.3 nucleo-
somes in the presence and absence of Hira.
Recent studies have shown that the Drosophila homolog of
Atrx, XNP, colocalizes with H3.3 at sites of nucleosome replace-
ment on polytene chromosomes but is not required for H3.3
localization at these sites (Schneiderman et al., 2009). We find
that Atrx is required for enrichment of H3.3 at mammalian ESC
telomeres, suggesting a divergence of homolog function. More-
over, we demonstrate that in the absence of Atrx, ESCs show
upregulation of TERRA. Could ATRX and Daxx serve as specific
H3.3 variant deposition machinery for specialized regions of
heterochromatin? The ATRX/Daxx complex has previously
been shown to have chromatin remodeling activity (Tang et al.,2004; Xue et al., 2003), and we show that Atrx is physically asso-
ciated with ESC telomeres. In addition to telomeres, our prelim-
inary studies indicate that Atrx is also required for H3.3 enrich-
ment at ribosomal DNA (data not shown), another transcribed
repetitive element with characteristics of heterochromatin
(McStay and Grummt, 2008).
Our findings raise multiple questions. What is the function of
H3.3 at genes, TFBS, and telomeres? Do cellular requirements
for H3.3 differ in dividing versus postmitotic cells, where replica-
tion-independent deposition might play a larger role? Is Atrx-
mediated localization of H3.3 also replication independent, like
Hira, or does it occur during replication? Broadly, our study rai-
ses the prospect that distinct, region-specific chaperone and
remodeling complexes may mediate the localization of a single
histone variant (H3.3) to particular genomic regions. Although
key factors required for region-specific H3.3 localization have
now been identified, the exact deposition mechanisms at play
remain an important challenge for future work.
EXPERIMENTAL PROCEDURES
ESC Culture and Differentiation
Mouse ESCs were cultured under standard conditions and differentiated to
NPCs as previously described (Conti et al., 2005). Hira/, Atrxflox, and Atrxnull
ESCs have been described previously (Garrick et al., 2006; Meshorer et al.,
2006). For more detail, see the Extended Experimental Procedures.
ZFN Design, Targeting, and Verification
ZFNs directed against themouseH3.3B genewere designedwith an archive of
validated two-finger modules (Doyon et al., 2008; Urnov et al., 2005). ESCs
were transfected with ZFNs and donor with Amaxa nucleofection. Fluorescent
ESC colonies were picked and screened by genomic PCR of H3.3B alleles,
sequencing of PCR products, flow cytometry, and Southern blot. For more
detail, see the Extended Experimental Procedures.
Cellular Extract Preparation
Whole-cell extracts were prepared by resuspension of cell pellets in SDS-
Laemmli sample buffer, followed by brief sonication and boiling.
ChIP and ChIP-Seq
Crosslinking and native ChIP were performed as described (Barski et al., 2007;
Lee et al., 2006), with minor modifications as detailed in the Extended Exper-
imental Procedures. ChIP DNA was validated by real-time PCR, prepared for
Illumina/Solexa sequencing, and sequenced with the Illumina Genome
Analyzer II. The CTD4H8 antibody was raised against a chemically synthesized
phospho-Ser 5 peptide sequence from the C-terminal domain (CTD) of the
largest RPB1 subunit of RNAPII and has been extensively characterized previ-
ously (Stock et al., 2007). Other antibodies and more detailed ChIP-seq
methods are described in the Extended Experimental Procedures. ChIP-seq
assays performed are listed in Table S5. To confirm telomere enrichment,
ChIP DNA from Atrxflox and Atrxnull ESCs was probed with a TTAGGG repeat
probe as described (Sfeir et al., 2009).
ChIP-Seq Data Analysis
ChIP-seq or input reads were mapped to the mouse genome (build 37, or
mm9) using the ELAND alignment software within the Illumina Analysis Pipe-
line. Profiles in specific genomic regions were displayed in the Affymetrix Inte-
grated Genome Browser. For analysis of repetitive elements, reads were
aligned directly to a library of mouse consensus repetitive sequences (http://
www.girinst.org/) and enrichments were computed for ChIP against input
samples. For TSS/TES profiling, we segregated reference genes (refSeq)
into low, medium, and high expression based on a previous microarray anal-
ysis (Mikkelsen et al., 2007). For TFBS profiling, binding sites for 13 TFs in
mouse ESCs were obtained from a previous ChIP-seq analysis (Chen et al.,Cell 140, 678–691, March 5, 2010 ª2010 Elsevier Inc. 687
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2008). To generate density profiles ±5 kb around TSS, TES, bivalent genes,
and TFBS, we used a sliding-window method to count the number of ChIP-
seq reads in each 200 bp window, and the resulting counts were then normal-
ized by the totals of genes or TFBS and the total mapped reads. For details of
data analysis, see the Extended Experimental Procedures.
Gene Expression Analysis of Wild-Type and Hira/ ESCs
RNA expression data for W9.5 and Hira/ ESCs was generated from polyA
RNA and random primers with the GeneChip Mouse Gene 1.0 ST Array kit
(Affymetrix).
Isolation of Protein Complexes and Mass Spectrometric Analysis
Immunoaffinity purifications of EYFP-tagged H3.3, H3.2, H3.1, HIRA/ H3.3,
and HIRA/ H3.2 were performed as described (Cristea et al., 2005). Matrix-
assisted laser desorption/ionization mass spectrometry (MALDI MS) and
tandem mass spectrometry (MS/MS) analyses were performed as described
(Luo et al., 2009). For more detail, see the Extended Experimental Procedures.
Immunofluorescence and Telomere Fluorescence In Situ
Hybridization
Telomere fluorescence in situ hybridization (FISH) of ESCswas performedwith
a peptide nucleic acid TAMRA-TelG telomere probe (Sfeir et al., 2009), and
immunofluorescence was performed with a previously described anti-GFP
antibody (Cristea et al., 2005). For more detail, see the Extended Experimental
Procedures.
TERRA Analysis
RNA was isolated with RNeasy Mini Kit (QIAGEN), and TERRA analysis was
performed as described (Azzalin et al., 2007; Sfeir et al., 2009).
ACCESSION NUMBERS
Our ChIP-seq and microarray data sets have been deposited in the GEO data-
base with accession numbers GSE16893 and GSE19542.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and five tables and can be found with this article online at doi:10.1016/
j.cell.2010.01.003.
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